Published in Nephrol Dial Transplant on December 01, 1997
Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ (2008) 3.35
Consensus statement on management of dyslipidemia in Indian subjects. Indian Heart J (2014) 1.57
Abnormalities of endothelial function in patients with predialysis renal failure. Heart (2000) 1.43
Evidence-based practice guideline for the treatment of CKD. Clin Exp Nephrol (2009) 1.29
Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden. J Am Soc Nephrol (2015) 1.15
Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study. Am J Kidney Dis (2009) 1.06
Healthy lifestyle and risk of kidney disease progression, atherosclerotic events, and death in CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis (2014) 1.05
Homocysteine lowering and cardiovascular disease risk: lost in translation. Can J Cardiol (2007) 0.98
Hypoalbuminaemia--a marker of cardiovascular disease in patients with chronic kidney disease stages II-IV. Int J Med Sci (2008) 0.91
Chapter 3: Management of progression and complications of CKD. Kidney Int Suppl (2011) (2013) 0.88
Cardiovascular Complications in CKD Patients: Role of Oxidative Stress. Cardiol Res Pract (2011) 0.86
Comparison of lipid-related ratios for prediction of chronic kidney disease stage 3 or more in Korean adults. J Korean Med Sci (2012) 0.84
Estimate of dietary phosphorus intake using 24-h urine collection. J Clin Biochem Nutr (2014) 0.82
Chapter 5: Referral to specialists and models of care. Kidney Int Suppl (2011) (2013) 0.82
High-intensity statin therapy in patients with chronic kidney disease: a systematic review and meta-analysis. BMJ Open (2015) 0.80
Assessment of dyslipidemia in pre-dialysis patients in south-west Nigeria. Niger Med J (2014) 0.78
Darbepoetin alpha reduces oxidative stress and chronic inflammation in atherosclerotic lesions of apo E deficient mice in experimental renal failure. PLoS One (2014) 0.78
Pretransplant malnutrition, inflammation, and atherosclerosis affect cardiovascular outcomes after kidney transplantation. BMC Nephrol (2015) 0.77
Serum catalytic Iron: A novel biomarker for coronary artery disease in patients on maintenance hemodialysis. Indian J Nephrol (2013) 0.77
Frequency of cardiovascular risk factors and metabolic syndrome in patients with chronic kidney disease. Clin Med Res (2010) 0.77
Effects of exercise in renal transplant recipients. World J Transplant (2012) 0.75
Effects of bromocriptine mesylate on homocysteine and high-sensitivity C-reactive protein levels in patients with type-2 diabetes mellitus. J Cardiovasc Thorac Res (2016) 0.75
Efficacy of Statin Treatment in Early-Stage Chronic Kidney Disease. PLoS One (2017) 0.75
Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state. World J Nephrol (2015) 0.75
Impact of coronary artery bypass surgery and percutaneous coronary intervention on mortality in patients with chronic kidney disease and on dialysis: A systematic review and meta-analysis. Medicine (Baltimore) (2016) 0.75
Risk factors for cardiovascular events among Asian patients without pre-existing cardiovascular disease on the renal transplant wait list. ASEAN Heart J (2015) 0.75
Malnutrition-inflammation-atherosclerosis syndrome in Chronic Kidney disease. Indian J Clin Biochem (2008) 0.75
QT dispersion increases with low glomerular filtration rate in patients with coronary artery disease. Pak J Med Sci (2014) 0.75
Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy. Lancet (1995) 5.77
Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol (2000) 5.26
Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int (1996) 3.62
Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest (2000) 3.60
FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. Osteoporos Int (2011) 2.71
Influence of end-stage renal failure on concentrations of free apolipoprotein A-1 in serum. Clin Chem (1989) 2.00
Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol (1998) 1.97
Sex- and age-related composition of 10 617 calculi analyzed by infrared spectroscopy. Urol Res (1995) 1.91
Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients. Nephrol Dial Transplant (2001) 1.90
Late referral to maintenance dialysis: detrimental consequences. Nephrol Dial Transplant (1993) 1.85
Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients. Nephrol Dial Transplant (2001) 1.69
Cardiovascular disease after renal transplantation. J Am Soc Nephrol (1996) 1.58
Identification of crystals in kidneys of AIDS patients treated with foscarnet. Am J Kidney Dis (1998) 1.50
Sequential measurements of urinary albumin in recipients of renal allografts. Clin Chem (1991) 1.38
[Epidemiology of end-stage kidney failure in the Ile-de-France: a prospective cooperative study in 1998]. Nephrologie (2000) 1.37
Structural study of circulating thymic factor: a peptide isolated from pig serum. I. Isolation and purification. J Biol Chem (1977) 1.28
Liver resection and needle liver biopsy cause hematogenous dissemination of liver cells. Hepatology (1999) 1.28
Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int (1991) 1.26
Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: I, Medical staff. Lancet (1981) 1.21
Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha. Kidney Int (1990) 1.18
Effects of blood pressure and antihypertensive treatment on progression of advanced chronic renal failure. Am J Kidney Dis (1993) 1.18
Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units: II, Haemodialysis patients. Lancet (1981) 1.18
Neutrophil-derived long-lived oxidants in cystic fibrosis sputum. Am J Respir Crit Care Med (1995) 1.17
Pregnancy in women with impaired renal function. Clin Nephrol (1997) 1.16
Uremic toxicity: present state of the art. Int J Artif Organs (2001) 1.15
Renal hemodynamics and segmental tubular reabsorption in early type 1 diabetes. Kidney Int (1990) 1.13
Age and gender-related incidence of chronic renal failure in a French urban area: a prospective epidemiologic study. Nephrol Dial Transplant (1996) 1.12
Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum. Am J Respir Cell Mol Biol (1999) 1.08
Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: Chronic Haemodialysis And New Cardiac Markers Evaluation (CHANCE) study. Nephrol Dial Transplant (2001) 1.08
Microtiter plate assay for phagocyte-derived taurine-chloramines. J Clin Lab Anal (1992) 1.07
Early glomerular dysfunction in patients with sickle cell anemia. Am J Kidney Dis (1998) 1.07
Detrimental effects of late referral in patients with chronic renal failure: a case-control study. Kidney Int Suppl (1993) 1.06
Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic Biol Med (1996) 1.06
Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection. Am J Clin Pathol (1999) 1.05
Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence. J Urol (2000) 1.03
Anemia and secondary hyperparathyroidism. Arch Intern Med (1978) 1.02
Generation of reactive oxygen species in whole blood from patients with acute falciparum malaria. Parasite Immunol (1987) 1.01
Disturbed myeloperoxidase-dependent activity of neutrophils in cystic fibrosis homozygotes and heterozygotes, and its correction by amiloride. J Immunol (1996) 1.00
One year follow-up of short dialysis with a membrane highly permeable to middle molecules. Proc Eur Dial Transplant Assoc (1973) 1.00
Serum activity of mitochondrial aspartate aminotransferase: a sensitive marker of alcoholism with or without alcoholic hepatitis. Hepatology (1984) 1.00
Crystalline phase differentiation in urinary calcium phosphate and magnesium phosphate calculi. Scand J Urol Nephrol (1999) 1.00
Influence of pregnancy on the course of primary chronic glomerulonephritis. Lancet (1995) 0.99
Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood. Kidney Int (1985) 0.99
Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant (2001) 0.99
Pregnancy in renal disease. Kidney Int (1997) 0.97
Up-to-date monitoring of childhood cancer long-term survival in Europe: tumours of the sympathetic nervous system, retinoblastoma, renal and bone tumours, and soft tissue sarcomas. Ann Oncol (2007) 0.97
Pregnancy in women with reflux nephropathy. Kidney Int (1996) 0.96
In vivo treatment with benzodiazepines inhibits murine phagocyte oxidative metabolism and production of interleukin 1, tumor necrosis factor and interleukin-6. J Pharmacol Exp Ther (1990) 0.94
Caspase-dependent apoptosis in THP-1 cells exposed to oxidized low-density lipoproteins. Biochem Biophys Res Commun (2000) 0.93
[2,8-dihydroxyadenine nephrolithiasis: from diagnosis to therapy]. Ann Biol Clin (Paris) (2007) 0.93
[Clinical value of crystalluria study]. Ann Biol Clin (Paris) (2004) 0.93
Characterization of a recombinant proteinase 3, the autoantigen in Wegener's granulomatosis and its reactivity with anti-neutrophil cytoplasmic autoantibodies. FEBS Lett (1996) 0.92
Progression rate to end-stage renal failure in non-diabetic kidney diseases: a multivariate analysis of determinant factors. Nephrol Dial Transplant (1995) 0.92
Abnormal vitamin D metabolism, intestinal calcium transport, and bone calcium status in the spontaneously hypertensive rat compared with its genetic control. J Clin Invest (1986) 0.92
Fourier transform infrared microscopy identification of crystal deposits in tissues: clinical importance in various pathologies. Am J Clin Pathol (1996) 0.92
Structural modifications of human beta 2 microglobulin treated with oxygen-derived radicals. Biochem J (1991) 0.92
In vitro suppression of cell-mediated immunity by ferroproteins and ferric salts. Cell Immunol (1983) 0.92
Serum mitochondrial aspartate aminotransferase as a marker of chronic alcoholism: diagnostic value and interpretation in a liver unit. Hepatology (1986) 0.92
Molecular expression of PSMA mRNA and protein in primary renal tumors. Int J Cancer (1999) 0.92
A new approach to studying inhibitors of calcium oxalate crystal growth. Urol Res (1993) 0.91
Hemofiltration, an alternative method for treatment of end-stage renal failure. Adv Nephrol Necker Hosp (1977) 0.90
Activation of phagocyte oxidative metabolism by opsonized Plasmodium falciparum merozoites. Acta Trop (1990) 0.90
Substitution of acetic acid for hydrochloric acid in the bicarbonate buffered dialysate. Artif Organs (1998) 0.90
Immune lysis of hepatocytes in culture: accurate detection by aspartate aminotransferase release measurement. J Immunol Methods (1984) 0.90
Inflammation and CFTR: might neutrophils be the key in cystic fibrosis? Mediators Inflamm (1999) 0.89
Effect of chronic renal failure on the expression and function of rat intestinal P-glycoprotein in drug excretion. Nephrol Dial Transplant (2001) 0.89
Modulation of human granulocyte and monocyte chemiluminescence responses: evidence for distinct free radical generating systems. J Clin Lab Immunol (1983) 0.89
Dyslipidaemia and the progression of renal disease in chronic renal failure patients. Nephrol Dial Transplant (1999) 0.88
The onset of left ventricular diastolic dysfunction in SHR rats is not related to hypertrophy or hypertension. Am J Physiol Heart Circ Physiol (2012) 0.88
Benzodiazepine anesthesia in humans modulates the interleukin-1 beta, tumor necrosis factor-alpha and interleukin-6 responses of blood monocytes. J Neuroimmunol (1991) 0.88
Central role of the transcription factor nuclear factor-kappa B in mesangial cell production of chemokines. Contrib Nephrol (1997) 0.88
Epidemiology of end-stage renal disease in the Ile-de-France area: a prospective study in 1998. Nephrol Dial Transplant (2000) 0.88
Advantage of zero-crossing-point first-derivative spectrophotometry for the quantification of calcium oxalate crystalline phases by infrared spectrophotometry. Clin Chim Acta (2000) 0.88
Defective complement receptors (CR1 and CR3) on erythrocytes and leukocytes of factor I (C3b-inactivator) deficient patients. Clin Exp Immunol (1986) 0.87
Factors affecting progression in advanced chronic renal failure. Clin Nephrol (1993) 0.87